Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.41 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4152203 | 0.94 | MAPT (0.45) | POLBL3MBTL1MAPTTHRBMAPK1 | |
| SCHEMBL4152208 | 0.94 | MAPT (0.45) | POLBL3MBTL1MAPTTHRBMAPK1 | |
| SCHEMBL4148835 | 0.92 | TP53 (0.46) | POLBL3MBTL1MAPTTHRBMAPK1 | |
| SCHEMBL4148832 | 0.92 | TP53 (0.46) | POLBL3MBTL1MAPTTHRBMAPK1 | |
| SCHEMBL6428652 | 0.91 | SMN1; SMN2 (0.44) | POLBMAPK1SMN1; SMN2LMNAKDM4E | |
| SCHEMBL4156427 | 0.91 | MAPT (0.51) | POLBMAPTTHRBMAPK1LMNA | |
| SCHEMBL4156431 | 0.91 | MAPT (0.51) | POLBMAPTTHRBMAPK1LMNA | |
| SCHEMBL4149303 | 0.91 | PSEN1 (0.43) | POLBMAPTTHRBLMNATP53 | |
| SCHEMBL4149306 | 0.91 | PSEN1 (0.43) | POLBMAPTTHRBLMNATP53 | |
| SCHEMBL6428413 | 0.90 | THRB (0.46) | POLBCYP3A4L3MBTL1THRBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050074668-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2005-04-07 | — | — | US | disclosed |
| US-20030052310-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2003-03-20 | — | — | US | disclosed |
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | MICHOT CHRISTOPHE (FR) | 2002-01-24 | — | — | US | disclosed |
| US-6319428-B1 | Perfluorinated amide salts and their uses as ionic conducting materials | HYDRO-QUEBEC (CA) | 2001-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020009650-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, NHERF1, AFF2 | POLB 2282/4885CYP3A4 367/4885MAPK14 1915/4885 |
| US-20050074668-A1 | Perfluorinated amide salts and their uses as ionic conducting materials | AFF4, AFF2, AFF1 | POLB 1773/4885CYP3A4 1566/4885MAPK14 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.